Becotatug Vedotin (MRG003) in Previously Treated Advanced Hepatocellular Carcinoma

by | Apr 21, 2026 | Clinical Trials | 0 comments

​ Conditions: Hepato Cellular Carcinoma (HCC)

Interventions: Drug: MRG003

Sponsors: Fudan University

Recruiting Conditions: Hepato Cellular Carcinoma (HCC)
Interventions: Drug: MRG003
Sponsors: Fudan University
Recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *